| ²é¿´: 823 | »Ø¸´: 18 | |||
| µ±Ç°Ö÷ÌâÒѾ´æµµ¡£ | |||
| ¡¾ÐüÉͽð±Ò¡¿»Ø´ð±¾ÌûÎÊÌ⣬×÷Õßxjxlovelxl½«ÔùËÍÄú 57 ¸ö½ð±Ò | |||
xjxlovelxlÈÙÓþ°æÖ÷ (ÖªÃû×÷¼Ò)
CA-FANS
|
[ÇóÖú]
[·ÅÆúÇóÖú,Çë°ßÖñɾÌù]¡ô×ö¿¹Ö×Áö×÷ÓûúÖÆ¿ÉÒÔ²éÔÄÄÄЩÍâÎÄÊý¾Ý¿â»ñÈ¡Ïà¹ØÎÄÏסô
|
||
![]() [ Last edited by xjxlovelxl on 2008-1-24 at 22:42 ] |
» ²ÂÄãϲ»¶
285Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
ÕÐÊÕ²©Ê¿1-2ÈË
ÒѾÓÐ4È˻ظ´
08¹¤¿Æ 320×Ü·Ö Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
ÉúÎïѧһ־Ը985£¬·ÖÊý349Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
0856²ÄÁÏר˶353Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
ɽ¶«Ê¡ÃæÉÏÏîÄ¿ÏÞ¶îÆÀÉó
ÒѾÓÐ4È˻ظ´
Ò»Ö¾Ô¸±±¾©»¯¹¤´óѧ070300 ѧ˶336Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
ÉúÎïѧ071000 329·ÖÇóµ÷¼Á
ÒѾÓÐ4È˻ظ´
Ò»Ö¾Ô¸»ªÖпƼ¼´óѧ071000£¬Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´

asbaggio1977
½ð³æ (ÕýʽдÊÖ)
- ²©Ñ§EPI: 1
- Ó¦Öú: 7 (Ó×¶ùÔ°)
- ½ð±Ò: 1448.1
- ºì»¨: 1
- Ìû×Ó: 530
- ÔÚÏß: 60.4Сʱ
- ³æºÅ: 485984
- ×¢²á: 2007-12-27
- ÐÔ±ð: GG
- רҵ: ÉúÎïÎÞ»ú»¯Ñ§
¡ï ¡ï
xjxlovelxl(½ð±Ò+2,VIP+0):ллÄãµÄ½â´ð£¬Ï£ÍûÄܸüÏ꾡µÄ½éÉÜһϣ¬ÎÒÒÔǰû×ö¹ý£¬ÊǸöÉúÊÖ
xjxlovelxl(½ð±Ò+2,VIP+0):ллÄãµÄ½â´ð£¬Ï£ÍûÄܸüÏ꾡µÄ½éÉÜһϣ¬ÎÒÒÔǰû×ö¹ý£¬ÊǸöÉúÊÖ
|
cancer letters, cancer research, J. Med. ChemµÈ Ö×Áöϸ°ûÖêÌ«¶àÑ¡ÔñÁË¡£ |

2Â¥2008-01-17 12:35:44
asbaggio1977
½ð³æ (ÕýʽдÊÖ)
- ²©Ñ§EPI: 1
- Ó¦Öú: 7 (Ó×¶ùÔ°)
- ½ð±Ò: 1448.1
- ºì»¨: 1
- Ìû×Ó: 530
- ÔÚÏß: 60.4Сʱ
- ³æºÅ: 485984
- ×¢²á: 2007-12-27
- ÐÔ±ð: GG
- רҵ: ÉúÎïÎÞ»ú»¯Ñ§

3Â¥2008-01-17 12:37:16
xjxlovelxl
ÈÙÓþ°æÖ÷ (ÖªÃû×÷¼Ò)
CA-FANS
- ²©Ñ§EPI: 7
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ¹ó±ö: 2.962
- ½ð±Ò: 1168
- É¢½ð: 5254
- ºì»¨: 3
- Ìû×Ó: 5985
- ÔÚÏß: 116Сʱ
- ³æºÅ: 291151
- ×¢²á: 2006-10-28
- ÐÔ±ð: MM
- רҵ: ѪҺϵͳ¼²²¡ÕïÁÆÐ¼¼Êõ
- ¹ÜϽ: Óн±ÎÊ´ð

4Â¥2008-01-17 12:39:47
Airare
½ð³æ (ÕýʽдÊÖ)
³æÓÎÌìÏÂ
- Ó¦Öú: 2 (Ó×¶ùÔ°)
- ½ð±Ò: 1409.2
- É¢½ð: 56
- ºì»¨: 1
- Ìû×Ó: 667
- ÔÚÏß: 52.5Сʱ
- ³æºÅ: 442605
- ×¢²á: 2007-10-27
- רҵ: ϸ°ûÐźÅתµ¼
¡ï ¡ï ¡ï ¡ï ¡ï
xjxlovelxl(½ð±Ò+5,VIP+0):ллÄúµÄ°ï棬ÒÔºó»¹Íû¶à¶à´Í½Ì£¡:)
xjxlovelxl(½ð±Ò+5,VIP+0):ллÄúµÄ°ï棬ÒÔºó»¹Íû¶à¶à´Í½Ì£¡:)
|
pubmed ,sciencedirect,wileyµÈµÈ¶¼ÊÇÉúÎïÀàÊý¾Ý¿â£¬¿´ÄãÊÇÑо¿Ê²Ã´°©Ö¢£¬¸Î°©£¬ÈéÏÙ°©¡£¡£¡£¡£¿ÉÒÔÏÈÕÒÕÒ×ÛÊö¿´¿´£¬ÈçNatureµÄ£¬CellµÄ£¬Cancer CellµÄ¡£ http://www.cancercell.org/°©Ï¸°û http://www.annualreviews.org/institutions/resources.aspx ×ÛÊöÄ꿯 ¡£¡£¡£ |

5Â¥2008-01-17 12:43:58
asbaggio1977
½ð³æ (ÕýʽдÊÖ)
- ²©Ñ§EPI: 1
- Ó¦Öú: 7 (Ó×¶ùÔ°)
- ½ð±Ò: 1448.1
- ºì»¨: 1
- Ìû×Ó: 530
- ÔÚÏß: 60.4Сʱ
- ³æºÅ: 485984
- ×¢²á: 2007-12-27
- ÐÔ±ð: GG
- רҵ: ÉúÎïÎÞ»ú»¯Ñ§

6Â¥2008-01-17 12:46:21
nucleus01
ÖÁ×ðľ³æ (ÖøÃûдÊÖ)
Сľ³æ±±Í¥½Ú¶Èʹ
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ¹ó±ö: 0.11
- ½ð±Ò: 15488.1
- ºì»¨: 1
- Ìû×Ó: 2930
- ÔÚÏß: 108.4Сʱ
- ³æºÅ: 165700
- ×¢²á: 2006-01-13
- ÐÔ±ð: GG
- רҵ: ÎïÀí
¡ï ¡ï ¡ï ¡ï ¡ï
xjxlovelxl(½ð±Ò+2,VIP+0):Ŷ~~~ºÃ¶à°¡,ºÃ¸´ÔÓ°¡;)ллÄúµÄ°ïÖú£¡
Â¥À¼ÉÙÅ®(½ð±Ò+3,VIP+0):ȷʵ²»´í£¬¿ÉÒÔ¼ÓÉÏÔÎÄ
xjxlovelxl(½ð±Ò+2,VIP+0):Ŷ~~~ºÃ¶à°¡,ºÃ¸´ÔÓ°¡;)ллÄúµÄ°ïÖú£¡
Â¥À¼ÉÙÅ®(½ð±Ò+3,VIP+0):ȷʵ²»´í£¬¿ÉÒÔ¼ÓÉÏÔÎÄ
|
www.pubmed.orgÃâ·ÑµÄÊý¾Ý¿â²éѯϵͳ£¬²»ÄÜÖ±½ÓÏÂÔØÎÄÏס£µ«¸²¸ÇµÄÊý¾Ý¿âºÍ¿¯ÎïºÜ¶à¡£¿ÉÒÔÓÃendnoteÖ±½ÓÁ¬½Ó²éѯ¡£ seicncedirect , wiley , springerlink ,proquestµÈ¶¼ÊÇ¿ÉÖ±½Ó²éѯÏÂÔØÎÄÏ×µÄÊý¾Ý¿â£¬ÏÂÔØÐèÒªÓÐȨÏÞ¡£ ÓÃanti-tumorΪ¹Ø¼ü´Ê ÔÚpubmedÖвéÁËЩ×ÛÊö£¬¹²23ƪ¡£Äã¿´¿´ÓÐûÓÐÓ㺠1: Related Articles, LinksHadaschik BA, Gleave ME. Therapeutic options for hormone-refractory prostate cancer in 2007. Urol Oncol. 2007 Sep-Oct;25(5):413-9. Review. PMID: 17826663 [PubMed - indexed for MEDLINE]2: Related Articles, LinksWoodworth T, Furst DE, Alten R, Bingham C, Yocum D, Sloan V, Tsuji W, Stevens R, Fries J, Witter J, Johnson K, Lassere M, Brooks P. Standardizing assessment and reporting of adverse effects in rheumatology clinical trials II: the Rheumatology Common Toxicity Criteria v.2.0. J Rheumatol. 2007 Jun;34(6):1401-14. PMID: 17552067 [PubMed - indexed for MEDLINE]3: Related Articles, LinksMacDonald JK, McDonald JW. Natalizumab for induction of remission in Crohn's disease. Cochrane Database Syst Rev. 2007 Jan 24;(1):CD006097. Review. PMID: 17253580 [PubMed - indexed for MEDLINE]4: Related Articles, LinksGartlehner G, Hansen RA, Jonas BL, Thieda P, Lohr KN. The comparative efficacy and safety of biologics for the treatment of rheumatoid arthritis: a systematic review and metaanalysis. J Rheumatol. 2006 Dec;33(12):2398-408. Review. PMID: 17225293 [PubMed - indexed for MEDLINE]5: Related Articles, LinksMacdonald JK, McDonald JW. Natalizumab for induction of remission in Crohn's disease. Cochrane Database Syst Rev. 2006 Jul 19;3:CD006097. Review. Update in: Cochrane Database Syst Rev. 2007;(1):CD006097. PMID: 16856112 [PubMed - indexed for MEDLINE]6: Related Articles, LinksCurtin JF, King GD, Candolfi M, Greeno RB, Kroeger KM, Lowenstein PR, Castro MG. Combining cytotoxic and immune-mediated gene therapy to treat brain tumors. Curr Top Med Chem. 2005;5(12):1151-70. Review. PMID: 16248789 [PubMed - indexed for MEDLINE]7: Related Articles, LinksAnolik JH, Aringer M. New treatments for SLE: cell-depleting and anti-cytokine therapies. Best Pract Res Clin Rheumatol. 2005 Oct;19(5):859-78. Review. PMID: 16150407 [PubMed - indexed for MEDLINE]8: Related Articles, LinksBraun J, Baraliakos X, Listing J, Sieper J. Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti-tumor necrosis factor agents infliximab and etanercept. Arthritis Rheum. 2005 Aug;52(8):2447-51. Review. PMID: 16052578 [PubMed - indexed for MEDLINE]9: Related Articles, LinksHomik JE, Suarez-Almazor M. An economic approach to health care. Best Pract Res Clin Rheumatol. 2004 Apr;18(2):203-18. Review. PMID: 15121040 [PubMed - indexed for MEDLINE]10: Related Articles, LinksLi WP, Anderson CJ. Imaging matrix metalloproteinase expression in tumors. Q J Nucl Med. 2003 Sep;47(3):201-8. Review. PMID: 12897711 [PubMed - indexed for MEDLINE]11: Related Articles, LinksMaksymowych WP, Inman RD, Gladman D, Thomson G, Stone M, Karsh J, Russell AS; Spondyloarthritis Research Consortium of Canada (SPARCC). Canadian Rheumatology Association Consensus on the use of anti-tumor necrosis factor-alpha directed therapies in the treatment of spondyloarthritis. J Rheumatol. 2003 Jun;30(6):1356-63. Review. PMID: 12784417 [PubMed - indexed for MEDLINE]12: Related Articles, LinksCao Y, Cao R, Veitonmäki N. Kringle structures and antiangiogenesis. Curr Med Chem Anticancer Agents. 2002 Nov;2(6):667-81. Review. PMID: 12678719 [PubMed - indexed for MEDLINE]13: Related Articles, LinksLovejoy DB, Richardson DR. Iron chelators as anti-neoplastic agents: current developments and promise of the PIH class of chelators. Curr Med Chem. 2003 Jun;10(12):1035-49. Review. PMID: 12678675 [PubMed - indexed for MEDLINE]14: Related Articles, LinksGrant S, Roberts JD. The use of cyclin-dependent kinase inhibitors alone or in combination with established cytotoxic drugs in cancer chemotherapy. Drug Resist Updat. 2003 Feb;6(1):15-26. Review. PMID: 12654284 [PubMed - indexed for MEDLINE]15: Related Articles, LinksBarnett KT, Malafa MP. Complications of hepatic artery infusion: a review of 4580 reported cases. Int J Gastrointest Cancer. 2001;30(3):147-60. Review. PMID: 12540027 [PubMed - indexed for MEDLINE]16: Related Articles, LinksKalos M. Tumor antigen-specific T cells and cancer immunotherapy: current issues and future prospects. Vaccine. 2003 Jan 30;21(7-8):781-6. Review. PMID: 12531359 [PubMed - indexed for MEDLINE]17: Related Articles, LinksJalkut MW, Reiter RE. Role of prostate stem cell antigen in prostate cancer research. Curr Opin Urol. 2002 Sep;12(5):401-6. Review. PMID: 12172427 [PubMed - indexed for MEDLINE]18: Related Articles, LinksMitchell MS. Cancer vaccines, a critical review--Part I. Curr Opin Investig Drugs. 2002 Jan;3(1):140-9. Review. PMID: 12054065 [PubMed - indexed for MEDLINE]19: Related Articles, LinksBordignon C, Carlo-Stella C, Colombo MP, De Vincentiis A, Lanata L, Lemoli RM, Locatelli F, Olivieri A, Rondelli D, Zanon P, Tura S. Cell therapy: achievements and perspectives. Haematologica. 1999 Dec;84(12):1110-49. Review. PMID: 10586214 [PubMed - indexed for MEDLINE]20: Related Articles, LinksAglietta M, Bertolini F, Carlo-Stella C, De Vincentiis A, Lanata L, Lemoli RM, Olivieri A, Siena S, Zanon P, Tura S. Ex vivo expansion of hematopoietic cells and their clinical use. 21: Related Articles, LinksNatanson C, Hoffman WD, Suffredini AF, Eichacker PQ, Danner RL. Selected treatment strategies for septic shock based on proposed mechanisms of pathogenesis. Ann Intern Med. 1994 May 1;120(9):771-83. Review. PMID: 8147551 [PubMed - indexed for MEDLINE]22: Related Articles, LinksBodmer M, Fournel MA, Hinshaw LB. Preclinical review of anti-tumor necrosis factor monoclonal antibodies. Crit Care Med. 1993 Oct;21(10 Suppl):S441-6. Review. PMID: 8403982 [PubMed - indexed for MEDLINE]23: Related Articles, LinksWherry JC, Pennington JE, Wenzel RP. Tumor necrosis factor and the therapeutic potential of anti-tumor necrosis factor antibodies. Crit Care Med. 1993 Oct;21(10 Suppl |

7Â¥2008-01-17 13:05:51
xjxlovelxl
ÈÙÓþ°æÖ÷ (ÖªÃû×÷¼Ò)
CA-FANS
- ²©Ñ§EPI: 7
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ¹ó±ö: 2.962
- ½ð±Ò: 1168
- É¢½ð: 5254
- ºì»¨: 3
- Ìû×Ó: 5985
- ÔÚÏß: 116Сʱ
- ³æºÅ: 291151
- ×¢²á: 2006-10-28
- ÐÔ±ð: MM
- רҵ: ѪҺϵͳ¼²²¡ÕïÁÆÐ¼¼Êõ
- ¹ÜϽ: Óн±ÎÊ´ð

8Â¥2008-01-17 16:52:49
xjxlovelxl
ÈÙÓþ°æÖ÷ (ÖªÃû×÷¼Ò)
CA-FANS
- ²©Ñ§EPI: 7
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ¹ó±ö: 2.962
- ½ð±Ò: 1168
- É¢½ð: 5254
- ºì»¨: 3
- Ìû×Ó: 5985
- ÔÚÏß: 116Сʱ
- ³æºÅ: 291151
- ×¢²á: 2006-10-28
- ÐÔ±ð: MM
- רҵ: ѪҺϵͳ¼²²¡ÕïÁÆÐ¼¼Êõ
- ¹ÜϽ: Óн±ÎÊ´ð

9Â¥2008-01-18 12:14:17
sunnyjane
½ð³æ (СÓÐÃûÆø)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 925.5
- Ìû×Ó: 142
- ÔÚÏß: 14.9Сʱ
- ³æºÅ: 440991
- ×¢²á: 2007-10-27
- ÐÔ±ð: MM
- רҵ: Ò©Îï·ÖÎö
¡ï ¡ï ¡ï ¡ï ¡ï
xjxlovelxl(½ð±Ò+5,VIP+0):ллÄúµÄÖ¸µ¼£¬ÎÒÏÖÔÚÊ×ÏÈҪȷ¶¨¶ÔÄÄÖÖÁö×îÓÐЧ£¬ËùÒԲŻáÑ¡ÔñÐÔµÄÈ¥×öһЩϸ°û
xjxlovelxl(½ð±Ò+5,VIP+0):ллÄúµÄÖ¸µ¼£¬ÎÒÏÖÔÚÊ×ÏÈҪȷ¶¨¶ÔÄÄÖÖÁö×îÓÐЧ£¬ËùÒԲŻáÑ¡ÔñÐÔµÄÈ¥×öһЩϸ°û
| ¿ÉÒÔÓÃÀ´×öʵÑéµÄϸ°ûÖêÖÖÀà·Ç³£¶à£¬µ«Äã±ØÐëÑ¡ÔñÄãÒª×öµÄÒ©ÎïËùÕë¶ÔµÄÖ×Áö£¬Õâ¸öÒ©¶ÔÄÄÖÖÖ×Áö×îÓÐЧ£¬µ±È»Ó¦¸ÃÊ×Ñ¡ÄÄÖÖϸ°ûÁË£¬ÁíÍâÒ»°ã·Î°©Ï¸°ûºÍ¸Î°©Ï¸°û×îºÃÅàÑø£¬Òª×öÂãÊó½ÓÖֵϰ£¬³ÉÁöÂÊÒ²×î¸ß¡£Äã¿ÉÒÔÏȲéÒ»ÏÂÄãÒª×öµÄÒ©ÎïÖ÷ÒªÊÇÕë¶Ôʲô°©µÄÔÙÈ·¶¨±È½ÏºÃÀ²¡£ÎÒÃÇÒÔǰÓиöÒ©¾ÍÊÇÕë¶ÔÈé°©µÄ£¬ÓÃÈËÈ鰩ϸ°ûЧ¹û¾Í·Ç³£ºÃ£¬Ó÷ΰ©Ï¸°ûÒª²îһЩ£¬µ«ÊÇÈ鰩ϸ°û²»Ì«ÈÝÒ×ÅàÑø£¬½ÓÖֳɹ¦ÂÊÒ²Ô¶µÍÓڷΰ©Ï¸°û¡£ |
10Â¥2008-01-18 13:18:17














»Ø¸´´ËÂ¥